Leveraging molecular structure and bioactivity with chemical language models for de novo drug design
M. Moret, I. P. Angona, et al.
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Leveraging Large Language Models for Precision Monitoring of Chemotherapy-Induced Toxicities: A Pilot Study with Expert Comparisons and Future Directions
O. R. Sarrias, M. P. M. D. Prado, et al.
The Goldilocks paradigm: comparing classical machine learning, large language models, and few-shot learning for drug discovery applications
S. H. Snyder, P. A. Vignaux, et al.
In Vitro Tumor Models on Chip and Integrated Microphysiological Analysis Platform (MAP) for Life Sciences and High-Throughput Drug Screening
H. Ngo, S. Amartumur, et al.
A comparative study of COVID-19 transcriptional signatures between clinical samples and preclinical cell models in the search for disease master regulators and drug repositioning candidates
H. Chapola, M. A. D. Bastiani, et al.
